. Fourier transform infrared spectroscopy (FTIR) of AuP-FAL and its intermediates. The strong peak at 1720 cm -1 was attributed to the C=O stretching in the DTPA chelators, scissor-like peaks at 1044 and 1193 cm -1 were assigned to the S=O stretching in the IR783B, a broad peak at 2800-2960 cm -1 was attributed to C−H stretching in PEGs, peaks at 1650 and 1550 cm -1 were assigned to typical amide bending in FAL peptides. Figure S8 . Average number of nanoprobe distributed in a selected area of tumor periphery and normal brain tissue. Above data were calculated from TEM images. All data are presented as mean ± SD. *, P < 0.05. Figure S9 . H&E staining of major organs (heart, liver, spleen, lung, kidney, brain) from healthy mice treated with PBS or AuP-FAL. The organs were harvested at 1 day or 7 days after intravenous injection, and then sectioned for histological staining. No obvious lesions were observed. Scale bar = 50 μm. Maximal absorption wavelength. c The molar ratios of gold nanoparticle/Gd 3+ /IR783B/PEG/FAL peptide in the nanoprobe. Number of Gd 3+ ions were determined by inductively coupled plasma atomic emission spectroscopy (ICP-AES). The average number of IR783B, PEG or FAL peptide labeled on the nanoprobe was quantified by gravimetric analysis. N.A. means Not Applicable.
